• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H5N1 血凝素受体结合域中的单个残基取代对于包装到假型慢病毒颗粒中至关重要。

A single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles.

机构信息

HKU-Pasteur Research Centre, The University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.

出版信息

PLoS One. 2012;7(11):e43596. doi: 10.1371/journal.pone.0043596. Epub 2012 Nov 2.

DOI:10.1371/journal.pone.0043596
PMID:23133587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3487904/
Abstract

BACKGROUND

Serological studies for influenza infection and vaccine response often involve microneutralization and hemagglutination inhibition assays to evaluate neutralizing antibodies against human and avian influenza viruses, including H5N1. We have previously characterized lentiviral particles pseudotyped with H5-HA (H5pp) and validated an H5pp-based assay as a safe alternative for high-throughput serological studies in BSL-2 facilities. Here we show that H5-HAs from different clades do not always give rise to efficient production of H5pp and the underlying mechanisms are addressed.

METHODOLOGY/FINDINGS: We have carried out mutational analysis to delineate the molecular determinants responsible for efficient packaging of HA from A/Cambodia/40808/2005 (H5Cam) and A/Anhui/1/2005 (H5Anh) into H5pp. Our results demonstrate that a single A134V mutation in the 130-loop of the receptor binding domain is sufficient to render H5Anh the ability to generate H5Anh-pp efficiently, whereas the reverse V134A mutation greatly hampers production of H5Cam-pp. Although protein expression in total cell lysates is similar for H5Anh and H5Cam, cell surface expression of H5Cam is detected at a significantly higher level than that of H5Anh. We further demonstrate by several independent lines of evidence that the behaviour of H5Anh can be explained by a stronger binding to sialic acid receptors implicating residue 134.

CONCLUSIONS

We have identified a single A134V mutation as the molecular determinant in H5-HA for efficient incorporation into H5pp envelope and delineated the underlying mechanism. The reduced binding to sialic acid receptors as a result of the A134V mutation not only exerts a critical influence in pseudotyping efficiency of H5-HA, but has also an impact at the whole virus level. Because A134V substitution has been reported as a naturally occurring mutation in human host, our results may have implications for the understanding of human host adaptation of avian influenza H5N1 viruses.

摘要

背景

流感感染和疫苗反应的血清学研究通常涉及微量中和和血凝抑制试验,以评估针对人源和禽流感病毒(包括 H5N1)的中和抗体。我们之前已经对带有 H5-HA(H5pp)的慢病毒颗粒进行了特征描述,并验证了基于 H5pp 的检测方法可作为在 BSL-2 设施中进行高通量血清学研究的安全替代方法。在此,我们表明,来自不同谱系的 H5-HA 并不总能导致 H5pp 的有效产生,并解决了潜在的机制。

方法/发现:我们进行了突变分析,以描绘负责将 A/Cambodia/40808/2005(H5Cam)和 A/Anhui/1/2005(H5Anh)的 HA 有效包装到 H5pp 中的分子决定因素。我们的结果表明,受体结合域 130 环中的单个 A134V 突变足以使 H5Anh 具有有效产生 H5Anh-pp 的能力,而相反的 V134A 突变则极大地阻碍了 H5Cam-pp 的产生。尽管 H5Anh 和 H5Cam 在总细胞裂解物中的蛋白表达相似,但 H5Cam 的细胞表面表达水平明显高于 H5Anh。我们还通过几条独立的证据进一步证明,H5Anh 的行为可以通过与唾液酸受体的更强结合来解释,这暗示了残基 134。

结论

我们已经确定 H5-HA 中的单个 A134V 突变是有效掺入 H5pp 包膜的分子决定因素,并阐明了潜在的机制。由于 A134V 突变导致与唾液酸受体的结合减弱,不仅对 H5-HA 的假型效率产生关键影响,而且对整个病毒水平也有影响。由于 A134V 取代已被报道为人类宿主中的自然发生突变,我们的结果可能对理解禽流感 H5N1 病毒的人类宿主适应性具有重要意义。

相似文献

1
A single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles.H5N1 血凝素受体结合域中的单个残基取代对于包装到假型慢病毒颗粒中至关重要。
PLoS One. 2012;7(11):e43596. doi: 10.1371/journal.pone.0043596. Epub 2012 Nov 2.
2
Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis.血凝素假型慢病毒颗粒:一种新型禽H5N1流感血清诊断方法的特性研究
J Clin Virol. 2007 May;39(1):27-33. doi: 10.1016/j.jcv.2007.02.005. Epub 2007 Apr 3.
3
Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.人感染期间观察到高致病性禽流感 H5N1 病毒受体结合位点内取代的表型效应。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00195-20.
4
A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.一种新型的高致病性禽流感 H5N1 病毒的致病机制涉及血凝素介导的对血清先天抑制剂的抗性。
PLoS One. 2012;7(5):e36318. doi: 10.1371/journal.pone.0036318. Epub 2012 May 1.
5
Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.自由能模拟揭示了一种具有改变的受体结合特异性的双突变禽流感H5N1病毒血凝素。
J Comput Chem. 2009 Aug;30(11):1654-63. doi: 10.1002/jcc.21274.
6
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.实验性改造的流感 H5 HA 可使重组 H5 HA/H1N1 病毒在雪貂中通过呼吸道飞沫传播。
Nature. 2012 May 2;486(7403):420-8. doi: 10.1038/nature10831.
7
H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice.血凝素中具有K193E和G225E双突变的H5N1甲型流感病毒在小鼠中减毒且具有免疫原性。
J Gen Virol. 2015 Sep;96(9):2522-2530. doi: 10.1099/vir.0.000193. Epub 2015 May 21.
8
HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.H5N1 和 H7N9 流感病毒对人内皮细胞的 HA 依赖性嗜性由 HA 的稳定性降低决定,这使病毒能够应对内体酸化效率低下和组成型表达的 IFITM3。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01223-19.
9
A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.一种复制缺陷型流感病毒,同时携带 H5 和 H7 血凝素,可在小鼠中预防 H5N1 和 H7N9 感染。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.02154-20.
10
Insertion of Basic Amino Acids in the Hemagglutinin Cleavage Site of H4N2 Avian Influenza Virus (AIV)-Reduced Virus Fitness in Chickens is Restored by Reassortment with Highly Pathogenic H5N1 AIV.插入基本氨基酸可降低 H4N2 禽流感病毒(AIV)在鸡体内的适应度,而与高致病性 H5N1 AIV 重配可恢复其适应度。
Int J Mol Sci. 2020 Mar 28;21(7):2353. doi: 10.3390/ijms21072353.

引用本文的文献

1
Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution.针对H5Nx禽流感病毒的疫苗接种与抗病毒治疗:病毒控制或进化的先兆
Vaccines (Basel). 2023 Oct 24;11(11):1628. doi: 10.3390/vaccines11111628.
2
Pseudotyped Viruses.伪型病毒。
Adv Exp Med Biol. 2023;1407:1-27. doi: 10.1007/978-981-99-0113-5_1.
3
Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain.人 C1q 通过其球形结构域调节甲型流感病毒感染和炎症反应。

本文引用的文献

1
Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.流感假型慢病毒颗粒的生产及其在流感研究和诊断中的应用:更新。
Expert Rev Anti Infect Ther. 2011 Apr;9(4):443-55. doi: 10.1586/eri.11.25.
2
Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.柬埔寨 1 分支高致病性 H5N1 流感病毒的神经氨酸酶抑制剂敏感性和受体结合特异性。
Antimicrob Agents Chemother. 2011 May;55(5):2004-10. doi: 10.1128/AAC.01773-10. Epub 2011 Feb 22.
3
The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets.
Int J Mol Sci. 2022 Mar 11;23(6):3045. doi: 10.3390/ijms23063045.
4
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus.C4 结合蛋白作为抗甲型流感病毒的固有免疫效应因子。
Front Immunol. 2021 Jan 8;11:585361. doi: 10.3389/fimmu.2020.585361. eCollection 2020.
5
Complete Genome Sequence of the First H5N1 Avian Influenza Virus Isolated from Chickens in Lebanon in 2016.2016年从黎巴嫩鸡群中分离出的首例H5N1禽流感病毒的全基因组序列
Genome Announc. 2016 Oct 20;4(5):e01062-16. doi: 10.1128/genomeA.01062-16.
6
Comparison of lentiviruses pseudotyped with S proteins from coronaviruses and cell tropisms of porcine coronaviruses.用冠状病毒S蛋白假型化的慢病毒与猪冠状病毒细胞嗜性的比较。
Virol Sin. 2016 Feb;31(1):49-56. doi: 10.1007/s12250-015-3690-4. Epub 2016 Feb 19.
7
Pseudotype-based neutralization assays for influenza: a systematic analysis.基于假病毒的流感中和试验:系统分析
Front Immunol. 2015 Apr 29;6:161. doi: 10.3389/fimmu.2015.00161. eCollection 2015.
8
Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.通过针对A/越南/1194/2004血凝素的鼠源抗体鉴定出的H5N1流感病毒的广泛交叉反应性表位。
PLoS One. 2014 Jun 19;9(6):e99201. doi: 10.1371/journal.pone.0099201. eCollection 2014.
9
Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection.新城疫病毒(NDV)假型化HIV-荧光素酶病毒的包装及其在新城疫病毒感染中和试验中的应用
PLoS One. 2014 Jun 17;9(6):e99905. doi: 10.1371/journal.pone.0099905. eCollection 2014.
10
Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding.人类感染期间 H5N1 病毒血凝素的变化 - 对受体结合的影响。
Virology. 2013 Dec;447(1-2):326-37. doi: 10.1016/j.virol.2013.08.010. Epub 2013 Sep 17.
人感染 H5N1 流感病毒的 HA 和 NS 基因有助于在雪貂中产生高致病性。
PLoS Pathog. 2010 Sep 16;6(9):e1001106. doi: 10.1371/journal.ppat.1001106.
4
Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay.利用假型中和测定法检测大流行和季节性 A/H1N1 流感病毒之间的广泛交叉中和作用。
PLoS One. 2010 Jun 9;5(6):e11036. doi: 10.1371/journal.pone.0011036.
5
The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.甲型流感病毒血凝素的糖基化状态影响受体结合特异性。
Virology. 2010 Jul 20;403(1):17-25. doi: 10.1016/j.virol.2010.03.047. Epub 2010 May 2.
6
HIV-1 assembly in macrophages.HIV-1 在巨噬细胞中的组装。
Retrovirology. 2010 Apr 7;7:29. doi: 10.1186/1742-4690-7-29.
7
Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay.基于甲型流感病毒(H5)假型慢病毒颗粒的血清学检测方法的优化与评估。
J Clin Virol. 2010 Jan;47(1):29-33. doi: 10.1016/j.jcv.2009.10.009. Epub 2009 Nov 7.
8
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.使用表达流感血凝素和神经氨酸酶的假型病毒,对免疫小鼠和雪貂中针对H5N1进化枝的中和抗体反应进行测量。
Vaccine. 2009 Nov 12;27(48):6777-90. doi: 10.1016/j.vaccine.2009.08.056. Epub 2009 Sep 2.
9
HA-pseudotyped retroviral vectors for influenza antagonist screening.用于流感拮抗剂筛选的HA假型逆转录病毒载体
J Biomol Screen. 2009 Mar;14(3):294-302. doi: 10.1177/1087057108330786. Epub 2009 Feb 11.
10
Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1).迈向高致病性禽流感病毒(H5N1)统一命名系统。
Emerg Infect Dis. 2008 Jul;14(7):e1. doi: 10.3201/eid1407.071681.